No Data
Nexentis Expands Credit Facility Under Amended Financing Agreement
Nexentis Subsidiary MitoCareX Hits First Drug‐Discovery Milestone With Optimized Molecule
Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
Express News | Nexentis Announces Mitocarex Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
Nexentis Technologies | 10-Q: Quarterly report
Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone